Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial
暂无分享,去创建一个
A. Chanan-Khan | S. Stilgenbauer | A. Kater | S. O'brien | A. Mato | J. Seymour | R. Furman | P. Ghia | W. Jurczak | J. Woyach | K. Higgins | J. Byrd | Jennifer R. Brown | N. Bajwa | Talha Munir | P. A. Palhares de Miranda | E. John | M. de Borja | Paulo A Palhares de Miranda